Abstract
BACKGROUND: Disease modifying treatments (DMTs) currently under development for Alzheimer's disease, have the potential to prevent or postpone institutionalization and more expensive care and might delay institutionalization of persons with dementia. OBJECTIVE: The current study estimates costs of living in a nursing home for persons with dementia in the Netherlands to help inform economic evaluations of future DMTs. METHODS: Data were collected during semi-structured interviews with healthcare professionals and from the financial administration of a healthcare organization with several nursing homes. Personnel costs were calculated using a bottom-up approach by valuing the time estimates. Non-personnel costs were calculated using information from the financial administration of the healthcare organization. RESULTS: Total costs of a person with dementia per 24 hours, including both care staff and other healthcare providers, were € 151 for small-scale living wards and € 147 for independent living wards. Non-personnel costs were € 37 per day. CONCLUSION: This study provides Dutch estimates for total healthcare costs per day for institutionalized persons with dementia. These cost estimates can be used in cost-effectiveness analyses for future DMTs in dementia.
| Original language | English |
|---|---|
| Pages (from-to) | 359-366 |
| Number of pages | 8 |
| Journal | Journal of Alzheimer's disease : JAD |
| Volume | 89 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 30 Aug 2022 |
Bibliographical note
Funding Information:This work was sponsored by Biogen Netherlands B.V. through a contracted study grant. iMTA conducted this study independently. The funding party had no role in design, data collection and analysis of the study, nor did they have a role in the decision to publish or the preparation of the manuscript.
Publisher Copyright:
© 2022 - The authors. Published by IOS Press.
